CD34+/CD38- Stem Cell Burden Could Predict Chronic Myeloid Leukemia Patients’ Outcome

BACKGROUND: The current predictor of the Chronic myeloid leukemia (CML) patients’ outcome is the degree of response to targeted therapy; here we search for a biomarker predicting CML outcome before start of therapy. This study aimed to assess the impact of the CD34+/CD38- stem cells (SCs) burden in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fathy El-Metwaly, Noura, Aref, Salah, Ayed, Mohamed, Abdel Hamid, Manal, El-Sokkary, Ahmed M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858256/
https://www.ncbi.nlm.nih.gov/pubmed/34711000
http://dx.doi.org/10.31557/APJCP.2021.22.10.3237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858256/
https://www.ncbi.nlm.nih.gov/pubmed/34711000
http://dx.doi.org/10.31557/APJCP.2021.22.10.3237

Ejemplares similares